Related Experiment Video
Updated: May 12, 2026

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic
Published on: September 4, 2012
A lactating woman presenting with puerperal pneumococcal mastitis: a case report
Barbara Miedzybrodzki1, Mark Miller
1Division of Infectious Diseases, Jewish General Hospital, 3755 Cote-Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada. mmiller@jgh.mcgill.ca.
Puerperal pneumococcal mastitis is rare, with only four reported cases. This study reviews these cases and discusses the role of pneumococcal vaccines in prevention.
Area of Science:
- Infectious Diseases
- Obstetrics and Gynecology
- Vaccinology
Background:
- Streptococcus pneumoniae is an infrequent cause of soft-tissue infections.
- Puerperal mastitis is typically associated with other bacterial pathogens.
Purpose of the Study:
- To report a rare case of puerperal pneumococcal mastitis.
- To review existing literature on pneumococcal mastitis.
- To discuss the implications for pneumococcal vaccination strategies.
Main Methods:
- Case report of a 35-year-old woman with puerperal pneumococcal mastitis.
- Comprehensive literature search for similar cases of pneumococcal mastitis.
Main Results:
- This study presents the fourth documented case of puerperal pneumococcal mastitis.
- The review identified only three previously reported cases in the medical literature.
Conclusions:
- Puerperal pneumococcal mastitis is an exceptionally rare condition.
- The findings underscore the importance of considering Streptococcus pneumoniae in mastitis cases.
- The role of pneumococcal vaccines in preventing such infections warrants further discussion.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: